Complete news at...
Complete news at...
Complete news at...
The drugstore chain Walgreens is offering free clinic visits to people who lose their jobs and health insurance through the end of this year. Complete news at...
Complete news at...
Officials in the Obama administration are seeking to reassure an edgy public about a potential swine flu outbreak, stressing the need for patience and preparedness, not panic. Complete news at...
Complete news at...
Monday, April 27, 2009
Evidence Mounts That Short Or Poor Sleep Can Lead To Increased Eating And Risk Of Diabetes
Evidence Mounts That Short Or Poor Sleep Can Lead To Increased Eating And Risk Of Diabetes
Laboratory and epidemiological studies continue to show that sleep curtailment and/or decreased sleep quality can disturb neuroendocrine control of appetite, leading to overeating, and can decrease insulin and/or increase insulin resistance, both steps on the road to Type 2 diabetes. On April 22, at the Experimental Biology 2009 meeting in New Orleans, a panel of leading sleep researchers describes recent and new studies in this fast growing field.
Study Links Increased Risk Of Suicidal Behaviour In Adults To Sleep Problems
Adults who suffer chronic sleep problems may face an increased risk of suicidal behaviour, new research indicates. In a study to be presented on April 1, 2009 at the World Psychiatric Association international congress "Treatments in Psychiatry," scientists found that the more types of sleep disturbances people had, the more likely they were to have thoughts of killing themselves, engage in planning a suicidal act or make a suicide attempt.
Tips for shopping for health insurance
A health reporter talks to experts about how you can navigate the "minefield" of choosing a private health plan.
Cephalon Announces Positive Results From A Phase Three Study Of NUVIGIL In Jet Lag Disorder
Cephalon, Inc. (NASDAQ: CEPH) announced positive results from a phase three clinical trial of NUVIGIL® (armodafinil) Tablets [C-IV] as a treatment for excessive sleepiness associated with jet lag disorder. Based on these findings, Cephalon® will file a supplemental New Drug Application with the U.S. Food and Drug Administration to expand the indications for NUVIGIL during the third quarter of this year.
Diagnosis And Appropriate Treatment Of Chronic Insomnia Should Become The Target Of Public Health Policy, Findings Suggest
A study in the April 1 issue of the journal SLEEP is the first to demonstrate that chronic insomnia with objectively measured short sleep time is an independent and clinically significant risk factor for hypertension. Results indicate that participants with insomnia and an objectively measured, severely short sleep duration of less than five hours had a risk for hypertension that was 500 percent higher than participants without insomnia who slept more than six hours.
Make Money in Your Sleep
The Eyes Have It
Laboratory and epidemiological studies continue to show that sleep curtailment and/or decreased sleep quality can disturb neuroendocrine control of appetite, leading to overeating, and can decrease insulin and/or increase insulin resistance, both steps on the road to Type 2 diabetes. On April 22, at the Experimental Biology 2009 meeting in New Orleans, a panel of leading sleep researchers describes recent and new studies in this fast growing field.
Study Links Increased Risk Of Suicidal Behaviour In Adults To Sleep Problems
Adults who suffer chronic sleep problems may face an increased risk of suicidal behaviour, new research indicates. In a study to be presented on April 1, 2009 at the World Psychiatric Association international congress "Treatments in Psychiatry," scientists found that the more types of sleep disturbances people had, the more likely they were to have thoughts of killing themselves, engage in planning a suicidal act or make a suicide attempt.
Tips for shopping for health insurance
A health reporter talks to experts about how you can navigate the "minefield" of choosing a private health plan.
Cephalon Announces Positive Results From A Phase Three Study Of NUVIGIL In Jet Lag Disorder
Cephalon, Inc. (NASDAQ: CEPH) announced positive results from a phase three clinical trial of NUVIGIL® (armodafinil) Tablets [C-IV] as a treatment for excessive sleepiness associated with jet lag disorder. Based on these findings, Cephalon® will file a supplemental New Drug Application with the U.S. Food and Drug Administration to expand the indications for NUVIGIL during the third quarter of this year.
Diagnosis And Appropriate Treatment Of Chronic Insomnia Should Become The Target Of Public Health Policy, Findings Suggest
A study in the April 1 issue of the journal SLEEP is the first to demonstrate that chronic insomnia with objectively measured short sleep time is an independent and clinically significant risk factor for hypertension. Results indicate that participants with insomnia and an objectively measured, severely short sleep duration of less than five hours had a risk for hypertension that was 500 percent higher than participants without insomnia who slept more than six hours.
Make Money in Your Sleep
The Eyes Have It
Subscribe to:
Posts (Atom)
